Health care stocks rose Monday afternoon, with the NYSE Health Care Index adding 2% and the Health Care Select Sector SPDR Fund (XLV) climbing 2.4%.
The iShares Biotechnology ETF (IBB) jumped 4.6%.
In corporate news, President Donald Trump signed an executive order that will seek to lower prescription drug prices by tying the amount the government pays for some medicines to lower prices abroad. Trump also said he will seek to "cut out" pharmacy benefit managers. Shares of Pfizer (PFE), Johnson & Johnson (JNJ), Merck (MRK), AbbVie (ABBV) and Eli Lilly (LLY) rose. UnitedHealth (UNH), CVS Health (CVS) and Cigna (CI), the owners of the three largest PBMs, fell 0.3%, 4.6% and 6.2%.
KindlyMD (KDLY) shares soared 340% after the company said Monday it has entered into a definitive merger agreement with Nakamoto Holdings to start a Bitcoin treasury strategy.
CytomX Therapeutics (CTMX) shares surged 90% after the company reported better-than-expected Q1 results and "positive" interim trial results.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。